Opportunities for additional pharmaceutical product #patentprotection in Europe, based on the use of a drug to treat a patient exhibiting
June 2021
Opportunities for additional pharmaceutical product #patentprotection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Read more in the #HealthcareScanner article by Dr Laurence Gainey: hgf.com/healthcare-sca…